Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

China · Delayed Price · Currency is CNY

132.13

+22.02 (20.00%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
In Vitro Diagnostic Products	407.69M	510.90M	547.84M	3.56B	5.37B
In Vitro Diagnostic Products Growth	-20.20%	-6.74%	-84.60%	-33.76%	945.54%
Total	407.69M	510.90M	547.84M	3.56B	5.37B
Total Growth	-20.20%	-6.74%	-84.60%	-33.76%	945.54%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Foreign	42.37M	38.89M	2.21B	5.11B
Foreign Growth	8.94%	-98.24%	-56.78%	-
China	468.53M	508.95M	1.35B	262.81M
China Growth	-7.94%	-62.29%	413.56%	-
Total	510.90M	547.84M	3.56B	5.37B
Total Growth	-6.74%	-84.60%	-33.76%	-

Source: S&P Global Market Intelligence.